Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
19 hedge funds and large institutions have $21.3M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 5 closing their positions.
1,000% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 1
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
22.18% more ownership
Funds ownership: 36.86% → 59.03% (+22%)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
6% more funds holding
Funds holding: 18 → 19 (+1)
18% less capital invested
Capital invested by funds: $26M → $21.3M (-$4.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Syncona Portfolio
St Peter Port,
Guernsey
|
+$23.6M |
| 2 |
CA
CHI Advisors
New York
|
+$3.69M |
| 3 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$2.69M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$624K |
| 5 |
Renaissance Technologies
New York
|
+$292K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$3.52M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$866K |
| 3 |
Axa
Paris,
France
|
-$562K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$218K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$51K |
FRLN Hedge Fund Activity: Q1 2022 in Review
19 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2022, worth a combined $21.3M — down 18% from $26M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FRLN positions and 5 closed out — a net gain of 1 holder — while 11 added to existing stakes and 1 trimmed.
The largest buyer was Syncona Portfolio, adding an estimated $23.6M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $3.52M sold.
- 19 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2022, up from 18 in Q4 2021.
- Funds reported $21.3M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2022, down 18% quarter-over-quarter.
- 6 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2022 and 5 closed out, a net change of +1 holder.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q1 2022 was Syncona Portfolio, an estimated $23.6M added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2022 was Novo Holdings A/S, an estimated $3.52M sold.
Based on aggregated 13F filings for Q1 2022.